Global Octreotide Market Insights, Forecast to 2026

Publisher Name :
Date: 05-May-2020
No. of pages: 119
Inquire Before Buying

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach 66.36% in 2015. Novartis exports to other countries mainly in the form of finished drug.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Octreotide 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Octreotide 3900 industry.

Based on our recent survey, we have several different scenarios about the Octreotide 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 3 million in 2019. The market size of Octreotide 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Octreotide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Octreotide market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Octreotide market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Octreotide market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Octreotide market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Octreotide market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Octreotide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Octreotide market.

The following manufacturers are covered in this report:

- Novartis

- Sun Pharmaceutical

- Chengdu Tiantaishan pharmaceutical

- Sinopharm A-Think Pharmaceuticals

- Sihuan Pharmaceutical Holdings Group

- Shanghai Soho-Yiming Pharmaceuticals

- Yibin Pharmaceutical

Octreotide Breakdown Data by Type

- Octreotide Injection

- Octreotide Powder

- Octreotide Microspheres

Octreotide Breakdown Data by Application

- Treating Severe Diarrhea

- Treating Acromegaly

- Others

Global Octreotide Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Octreotide Product Introduction
1.2 Market Segments
1.3 Key Octreotide Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Octreotide Market Size Growth Rate by Type
1.4.2 Octreotide Injection
1.4.3 Octreotide Powder
1.4.4 Octreotide Microspheres
1.5 Market by Application
1.5.1 Global Octreotide Market Size Growth Rate by Application
1.5.2 Treating Severe Diarrhea
1.5.3 Treating Acromegaly
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Octreotide Industry Impact
1.6.1 How the Covid-19 is Affecting the Octreotide Industry
1.6.1.1 Octreotide Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Octreotide Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Octreotide Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Octreotide Market Size Estimates and Forecasts
2.1.1 Global Octreotide Revenue 2015-2026
2.1.2 Global Octreotide Sales 2015-2026
2.2 Octreotide Market Size by Region: 2020 Versus 2026
2.2.1 Global Octreotide Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Octreotide Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Octreotide Competitor Landscape by Players
3.1 Octreotide Sales by Manufacturers
3.1.1 Octreotide Sales by Manufacturers (2015-2020)
3.1.2 Octreotide Sales Market Share by Manufacturers (2015-2020)
3.2 Octreotide Revenue by Manufacturers
3.2.1 Octreotide Revenue by Manufacturers (2015-2020)
3.2.2 Octreotide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Octreotide Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Octreotide Revenue in 2019
3.2.5 Global Octreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Octreotide Price by Manufacturers
3.4 Octreotide Manufacturing Base Distribution, Product Types
3.4.1 Octreotide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Octreotide Product Type
3.4.3 Date of International Manufacturers Enter into Octreotide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Octreotide Market Size by Type (2015-2020)
4.1.1 Global Octreotide Sales by Type (2015-2020)
4.1.2 Global Octreotide Revenue by Type (2015-2020)
4.1.3 Octreotide Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Octreotide Market Size Forecast by Type (2021-2026)
4.2.1 Global Octreotide Sales Forecast by Type (2021-2026)
4.2.2 Global Octreotide Revenue Forecast by Type (2021-2026)
4.2.3 Octreotide Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Octreotide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Octreotide Market Size by Application (2015-2020)
5.1.1 Global Octreotide Sales by Application (2015-2020)
5.1.2 Global Octreotide Revenue by Application (2015-2020)
5.1.3 Octreotide Price by Application (2015-2020)
5.2 Octreotide Market Size Forecast by Application (2021-2026)
5.2.1 Global Octreotide Sales Forecast by Application (2021-2026)
5.2.2 Global Octreotide Revenue Forecast by Application (2021-2026)
5.2.3 Global Octreotide Price Forecast by Application (2021-2026)
6 North America
6.1 North America Octreotide by Country
6.1.1 North America Octreotide Sales by Country
6.1.2 North America Octreotide Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Octreotide Market Facts & Figures by Type
6.3 North America Octreotide Market Facts & Figures by Application
7 Europe
7.1 Europe Octreotide by Country
7.1.1 Europe Octreotide Sales by Country
7.1.2 Europe Octreotide Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Octreotide Market Facts & Figures by Type
7.3 Europe Octreotide Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Octreotide by Region
8.1.1 Asia Pacific Octreotide Sales by Region
8.1.2 Asia Pacific Octreotide Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Octreotide Market Facts & Figures by Type
8.3 Asia Pacific Octreotide Market Facts & Figures by Application
9 Latin America
9.1 Latin America Octreotide by Country
9.1.1 Latin America Octreotide Sales by Country
9.1.2 Latin America Octreotide Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Octreotide Market Facts & Figures by Type
9.3 Central & South America Octreotide Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Octreotide by Country
10.1.1 Middle East and Africa Octreotide Sales by Country
10.1.2 Middle East and Africa Octreotide Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Octreotide Market Facts & Figures by Type
10.3 Middle East and Africa Octreotide Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Octreotide Products Offered
11.1.5 Novartis Recent Development
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Corporation Information
11.2.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sun Pharmaceutical Octreotide Products Offered
11.2.5 Sun Pharmaceutical Recent Development
11.3 Chengdu Tiantaishan pharmaceutical
11.3.1 Chengdu Tiantaishan pharmaceutical Corporation Information
11.3.2 Chengdu Tiantaishan pharmaceutical Description, Business Overview and Total Revenue
11.3.3 Chengdu Tiantaishan pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Products Offered
11.3.5 Chengdu Tiantaishan pharmaceutical Recent Development
11.4 Sinopharm A-Think Pharmaceuticals
11.4.1 Sinopharm A-Think Pharmaceuticals Corporation Information
11.4.2 Sinopharm A-Think Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Sinopharm A-Think Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Products Offered
11.4.5 Sinopharm A-Think Pharmaceuticals Recent Development
11.5 Sihuan Pharmaceutical Holdings Group
11.5.1 Sihuan Pharmaceutical Holdings Group Corporation Information
11.5.2 Sihuan Pharmaceutical Holdings Group Description, Business Overview and Total Revenue
11.5.3 Sihuan Pharmaceutical Holdings Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Products Offered
11.5.5 Sihuan Pharmaceutical Holdings Group Recent Development
11.6 Shanghai Soho-Yiming Pharmaceuticals
11.6.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information
11.6.2 Shanghai Soho-Yiming Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Shanghai Soho-Yiming Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products Offered
11.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
11.7 Yibin Pharmaceutical
11.7.1 Yibin Pharmaceutical Corporation Information
11.7.2 Yibin Pharmaceutical Description, Business Overview and Total Revenue
11.7.3 Yibin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Yibin Pharmaceutical Octreotide Products Offered
11.7.5 Yibin Pharmaceutical Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Octreotide Products Offered
11.1.5 Novartis Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Octreotide Market Estimates and Projections by Region
12.1.1 Global Octreotide Sales Forecast by Regions 2021-2026
12.1.2 Global Octreotide Revenue Forecast by Regions 2021-2026
12.2 North America Octreotide Market Size Forecast (2021-2026)
12.2.1 North America: Octreotide Sales Forecast (2021-2026)
12.2.2 North America: Octreotide Revenue Forecast (2021-2026)
12.2.3 North America: Octreotide Market Size Forecast by Country (2021-2026)
12.3 Europe Octreotide Market Size Forecast (2021-2026)
12.3.1 Europe: Octreotide Sales Forecast (2021-2026)
12.3.2 Europe: Octreotide Revenue Forecast (2021-2026)
12.3.3 Europe: Octreotide Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Octreotide Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Octreotide Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Octreotide Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Octreotide Market Size Forecast by Region (2021-2026)
12.5 Latin America Octreotide Market Size Forecast (2021-2026)
12.5.1 Latin America: Octreotide Sales Forecast (2021-2026)
12.5.2 Latin America: Octreotide Revenue Forecast (2021-2026)
12.5.3 Latin America: Octreotide Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Octreotide Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Octreotide Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Octreotide Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Octreotide Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Octreotide Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Octreotide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Octreotide Market Segments
Table 2. Ranking of Global Top Octreotide Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Octreotide Market Size Growth Rate by Type 2020-2026 (Gram) & (US$ Million)
Table 4. Major Manufacturers of Octreotide Injection
Table 5. Major Manufacturers of Octreotide Powder
Table 6. Major Manufacturers of Octreotide Microspheres
Table 7. COVID-19 Impact Global Market: (Four Octreotide Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Octreotide Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Octreotide Players to Combat Covid-19 Impact
Table 12. Global Octreotide Market Size Growth Rate by Application 2020-2026 (Gram)
Table 13. Global Octreotide Market Size by Region (Gram) & (US$ Million): 2020 VS 2026
Table 14. Global Octreotide Sales by Regions 2015-2020 (Gram)
Table 15. Global Octreotide Sales Market Share by Regions (2015-2020)
Table 16. Global Octreotide Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Octreotide Sales by Manufacturers (2015-2020) (Gram)
Table 18. Global Octreotide Sales Share by Manufacturers (2015-2020)
Table 19. Global Octreotide Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Octreotide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Octreotide as of 2019)
Table 21. Octreotide Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Octreotide Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Octreotide Price (2015-2020) (USD/Gram)
Table 24. Octreotide Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Octreotide Product Type
Table 26. Date of International Manufacturers Enter into Octreotide Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Octreotide Sales by Type (2015-2020) (Gram)
Table 29. Global Octreotide Sales Share by Type (2015-2020)
Table 30. Global Octreotide Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Octreotide Revenue Share by Type (2015-2020)
Table 32. Octreotide Average Selling Price (ASP) by Type 2015-2020 (USD/Gram)
Table 33. Global Octreotide Sales by Application (2015-2020) (Gram)
Table 34. Global Octreotide Sales Share by Application (2015-2020)
Table 35. North America Octreotide Sales by Country (2015-2020) (Gram)
Table 36. North America Octreotide Sales Market Share by Country (2015-2020)
Table 37. North America Octreotide Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Octreotide Revenue Market Share by Country (2015-2020)
Table 39. North America Octreotide Sales by Type (2015-2020) (Gram)
Table 40. North America Octreotide Sales Market Share by Type (2015-2020)
Table 41. North America Octreotide Sales by Application (2015-2020) (Gram)
Table 42. North America Octreotide Sales Market Share by Application (2015-2020)
Table 43. Europe Octreotide Sales by Country (2015-2020) (Gram)
Table 44. Europe Octreotide Sales Market Share by Country (2015-2020)
Table 45. Europe Octreotide Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Octreotide Revenue Market Share by Country (2015-2020)
Table 47. Europe Octreotide Sales by Type (2015-2020) (Gram)
Table 48. Europe Octreotide Sales Market Share by Type (2015-2020)
Table 49. Europe Octreotide Sales by Application (2015-2020) (Gram)
Table 50. Europe Octreotide Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Octreotide Sales by Region (2015-2020) (Gram)
Table 52. Asia Pacific Octreotide Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Octreotide Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Octreotide Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Octreotide Sales by Type (2015-2020) (Gram)
Table 56. Asia Pacific Octreotide Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Octreotide Sales by Application (2015-2020) (Gram)
Table 58. Asia Pacific Octreotide Sales Market Share by Application (2015-2020)
Table 59. Latin America Octreotide Sales by Country (2015-2020) (Gram)
Table 60. Latin America Octreotide Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Octreotide Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Octreotide Revenue Market Share by Country (2015-2020)
Table 63. Latin America Octreotide Sales by Type (2015-2020) (Gram)
Table 64. Latin America Octreotide Sales Market Share by Type (2015-2020)
Table 65. Latin America Octreotide Sales by Application (2015-2020) (Gram)
Table 66. Latin America Octreotide Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Octreotide Sales by Country (2015-2020) (Gram)
Table 68. Middle East and Africa Octreotide Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Octreotide Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Octreotide Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Octreotide Sales by Type (2015-2020) (Gram)
Table 72. Middle East and Africa Octreotide Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Octreotide Sales by Application (2015-2020) (Gram)
Table 74. Middle East and Africa Octreotide Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Octreotide Production (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Sun Pharmaceutical Corporation Information
Table 81. Sun Pharmaceutical Description and Major Businesses
Table 82. Sun Pharmaceutical Octreotide Production (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2015-2020)
Table 83. Sun Pharmaceutical Product
Table 84. Sun Pharmaceutical Recent Development
Table 85. Chengdu Tiantaishan pharmaceutical Corporation Information
Table 86. Chengdu Tiantaishan pharmaceutical Description and Major Businesses
Table 87. Chengdu Tiantaishan pharmaceutical Octreotide Production (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2015-2020)
Table 88. Chengdu Tiantaishan pharmaceutical Product
Table 89. Chengdu Tiantaishan pharmaceutical Recent Development
Table 90. Sinopharm A-Think Pharmaceuticals Corporation Information
Table 91. Sinopharm A-Think Pharmaceuticals Description and Major Businesses
Table 92. Sinopharm A-Think Pharmaceuticals Octreotide Production (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2015-2020)
Table 93. Sinopharm A-Think Pharmaceuticals Product
Table 94. Sinopharm A-Think Pharmaceuticals Recent Development
Table 95. Sihuan Pharmaceutical Holdings Group Corporation Information
Table 96. Sihuan Pharmaceutical Holdings Group Description and Major Businesses
Table 97. Sihuan Pharmaceutical Holdings Group Octreotide Production (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2015-2020)
Table 98. Sihuan Pharmaceutical Holdings Group Product
Table 99. Sihuan Pharmaceutical Holdings Group Recent Development
Table 100. Shanghai Soho-Yiming Pharmaceuticals Corporation Information
Table 101. Shanghai Soho-Yiming Pharmaceuticals Description and Major Businesses
Table 102. Shanghai Soho-Yiming Pharmaceuticals Octreotide Production (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2015-2020)
Table 103. Shanghai Soho-Yiming Pharmaceuticals Product
Table 104. Shanghai Soho-Yiming Pharmaceuticals Recent Development
Table 105. Yibin Pharmaceutical Corporation Information
Table 106. Yibin Pharmaceutical Description and Major Businesses
Table 107. Yibin Pharmaceutical Octreotide Production (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2015-2020)
Table 108. Yibin Pharmaceutical Product
Table 109. Yibin Pharmaceutical Recent Development
Table 110. Global Octreotide Sales Forecast by Regions (2021-2026) (Gram)
Table 111. Global Octreotide Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Octreotide Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Octreotide Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Octreotide Sales Forecast by Country (2021-2026) (Gram)
Table 115. North America: Octreotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Octreotide Sales Forecast by Country (2021-2026) (Gram)
Table 117. Europe: Octreotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Octreotide Sales Forecast by Region (2021-2026) (Gram)
Table 119. Asia Pacific: Octreotide Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Octreotide Sales Forecast by Country (2021-2026) (Gram)
Table 121. Latin America: Octreotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Octreotide Sales Forecast by Country (2021-2026) (Gram)
Table 123. Middle East and Africa: Octreotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Octreotide Players
Table 128. Octreotide Customers List
Table 129. Octreotide Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Octreotide Product Picture
Figure 2. Global Octreotide Sales Market Share by Type in 2020 & 2026
Figure 3. Octreotide Injection Product Picture
Figure 4. Octreotide Powder Product Picture
Figure 5. Octreotide Microspheres Product Picture
Figure 6. Global Octreotide Sales Market Share by Application in 2020 & 2026
Figure 7. Treating Severe Diarrhea
Figure 8. Treating Acromegaly
Figure 9. Others
Figure 10. Octreotide Report Years Considered
Figure 11. Global Octreotide Market Size 2015-2026 (US$ Million)
Figure 12. Global Octreotide Sales 2015-2026 (Gram)
Figure 13. Global Octreotide Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Octreotide Sales Market Share by Region (2015-2020)
Figure 15. Global Octreotide Sales Market Share by Region in 2019
Figure 16. Global Octreotide Revenue Market Share by Region (2015-2020)
Figure 17. Global Octreotide Revenue Market Share by Region in 2019
Figure 18. Global Octreotide Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Octreotide Revenue in 2019
Figure 20. Octreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Octreotide Sales Market Share by Type (2015-2020)
Figure 22. Global Octreotide Sales Market Share by Type in 2019
Figure 23. Global Octreotide Revenue Market Share by Type (2015-2020)
Figure 24. Global Octreotide Revenue Market Share by Type in 2019
Figure 25. Global Octreotide Market Share by Price Range (2015-2020)
Figure 26. Global Octreotide Sales Market Share by Application (2015-2020)
Figure 27. Global Octreotide Sales Market Share by Application in 2019
Figure 28. Global Octreotide Revenue Market Share by Application (2015-2020)
Figure 29. Global Octreotide Revenue Market Share by Application in 2019
Figure 30. North America Octreotide Sales Growth Rate 2015-2020 (Gram)
Figure 31. North America Octreotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Octreotide Sales Market Share by Country in 2019
Figure 33. North America Octreotide Revenue Market Share by Country in 2019
Figure 34. U.S. Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 35. U.S. Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 37. Canada Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Octreotide Market Share by Type in 2019
Figure 39. North America Octreotide Market Share by Application in 2019
Figure 40. Europe Octreotide Sales Growth Rate 2015-2020 (Gram)
Figure 41. Europe Octreotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Octreotide Sales Market Share by Country in 2019
Figure 43. Europe Octreotide Revenue Market Share by Country in 2019
Figure 44. Germany Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 45. Germany Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 47. France Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 49. U.K. Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 51. Italy Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 53. Russia Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Octreotide Market Share by Type in 2019
Figure 55. Europe Octreotide Market Share by Application in 2019
Figure 56. Asia Pacific Octreotide Sales Growth Rate 2015-2020 (Gram)
Figure 57. Asia Pacific Octreotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Octreotide Sales Market Share by Region in 2019
Figure 59. Asia Pacific Octreotide Revenue Market Share by Region in 2019
Figure 60. China Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 61. China Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 63. Japan Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 65. South Korea Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 67. India Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 69. Australia Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 71. Taiwan Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 73. Indonesia Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 75. Thailand Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 77. Malaysia Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 79. Philippines Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 81. Vietnam Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Octreotide Market Share by Type in 2019
Figure 83. Asia Pacific Octreotide Market Share by Application in 2019
Figure 84. Latin America Octreotide Sales Growth Rate 2015-2020 (Gram)
Figure 85. Latin America Octreotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Octreotide Sales Market Share by Country in 2019
Figure 87. Latin America Octreotide Revenue Market Share by Country in 2019
Figure 88. Mexico Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 89. Mexico Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 91. Brazil Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 93. Argentina Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Octreotide Market Share by Type in 2019
Figure 95. Latin America Octreotide Market Share by Application in 2019
Figure 96. Middle East and Africa Octreotide Sales Growth Rate 2015-2020 (Gram)
Figure 97. Middle East and Africa Octreotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Octreotide Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Octreotide Revenue Market Share by Country in 2019
Figure 100. Turkey Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 101. Turkey Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 103. Saudi Arabia Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Octreotide Sales Growth Rate (2015-2020) (Gram)
Figure 105. UAE Octreotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Octreotide Market Share by Type in 2019
Figure 107. Middle East and Africa Octreotide Market Share by Application in 2019
Figure 108. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Chengdu Tiantaishan pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Sinopharm A-Think Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Sihuan Pharmaceutical Holdings Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Shanghai Soho-Yiming Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Yibin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Octreotide Sales Growth Rate Forecast (2021-2026) (Gram)
Figure 116. North America Octreotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Octreotide Sales Growth Rate Forecast (2021-2026) (Gram)
Figure 118. Europe Octreotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Octreotide Sales Growth Rate Forecast (2021-2026) (Gram)
Figure 120. Asia Pacific Octreotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Octreotide Sales Growth Rate Forecast (2021-2026) (Gram)
Figure 122. Latin America Octreotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Octreotide Sales Growth Rate Forecast (2021-2026) (Gram)
Figure 124. Middle East and Africa Octreotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs